CXCR3 and breast carcinoma: Studies demonstrate that malignant breast cancer cells, particularly aggressive basal types, express a higher CXCR3-A to CXCR3-B ratio compared to predominantly CXCR3-B-expressing non-malignant mammary epithelial cells [69].